Latest / Decera Clinical Education Oncology Podcast
FAQ on New Therapeutic Developments in Relapsed/Refractory Multiple Myeloma
In this episode, Jesús F. San-Miguel, MD, PhD; Paula Rodriguez-Otero, MD, PhD; and Prof. Dr. med. Katja Weisel answer questions focused on current and emerging therapies for early and late relapsed, refractory multiple myeloma, with topics including:
• Responses across different subgroups treated with idecabtagene vicleucel in the KarMMa trial
• Selecting therapy for a patient with lenalidomide-refractory disease at first relapse
• How CAR T-cell therapy, melflufen, and selinexor will fit into existing and future treatment algorithms
• Key findings from the DREAMM2 trial on belantamab…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.